Who’s Hired? Former Hikma Chief Olafsson Takes Lead At Mallinckrodt

As Teva Names New Global R&D And Chief Medical Officer

Siggi Olafsson has taken the reins at Mallinckrodt after stepping down as Hikma’s CEO. At the same time, Teva has named a new global R&D and chief medical officer while Piramal Pharma Solutions has appointed a fresh COO and Formycon has added to its supervisory board.

R&D Wooden Blocks
Teva has named a new global R&D and chief medical officer • Source: Shutterstock

Mallinckrodt has announced that Siggi Olafsson has joined the company as president and CEO and as a member of the company’s board, after stepping down as chief executive of Hikma earlier this year.

The appointment, which will see Olafsson replace former president and CEO Mark Trudeau, comes as Mallinckrodt announced that it has...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin